Clinical Trials on Steatohepatitis
Total 540 results
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
University of BathAbertay UniversityCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited Kingdom
-
Johane AllardCanadian Institutes of Health Research (CIHR); American College of GastroenterologyCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisCanada
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Germany, Argentina
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Mayo ClinicCompletedObesity | Non-Alcoholic Steatohepatitis
-
Natalie TorokActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
University Health Network, TorontoNovo Nordisk A/SEnrolling by invitationDiabetes Mellitus | NAFLD | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; ComplicationsCanada
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Oasis Pharmaceuticals, LLCMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...RecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Eccanga Pty LtdSyneos HealthRecruiting
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsRecruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverFinland, United Kingdom, Greece, Germany, Sweden, Spain, Italy, Switzerland, United States, France
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisHong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle UniversityCompletedNonalcoholic SteatohepatitisUnited Kingdom
-
Gannex Pharma Co., Ltd.RecruitingNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisChina
-
Great China Fatty Liver Consortium LimitedChinese University of Hong Kong; Virginia Commonwealth UniversityNot yet recruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver
-
Universidade Federal do ParanáActive, not recruitingLiver Diseases | Steatosis | Steatohepatitis, Nonalcoholic | SteatohepatitisBrazil
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingProbiotics | Non-Alcoholic Fatty Liver Disease | Microbiome | Gut Microbiome | Fecal Microbiota Transplantation | Intestinal Microbiome | FMT | Non Alcoholic Steatohepatitis | PrebioticsNetherlands
-
Boehringer IngelheimRecruitingObesity | Non-Alcoholic SteatoHepatitis (NASH)United States
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Chinese University of Hong KongNot yet recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Hong Kong
-
Johns Hopkins UniversityReShape LifesciencesWithdrawnObesity | Obesity, Morbid | NASH - Nonalcoholic Steatohepatitis
-
NHS TaysideCompletedInsulin Sensitivity | NASH - Nonalcoholic SteatohepatitisUnited Kingdom
-
Tanta UniversityActive, not recruitingNon-alcoholic SteatohepatitisEgypt
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
Melinta Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Franciscus GasthuisErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsNot yet recruitingNAFLD | Obesity, Morbid | NASH - Nonalcoholic SteatohepatitisNetherlands
-
University Hospital, LilleRégion Nord-Pas de Calais, France; RHU PreciNASH Task 1.4RecruitingObesity | NASH - Nonalcoholic SteatohepatitisFrance
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
PerspectumKing's College Hospital NHS Trust; University of Coimbra; Liverpool University... and other collaboratorsCompletedMetabolic Syndrome | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited Kingdom, Germany, Netherlands, Portugal
-
Indiana University School of MedicineTerminatedHIV Infections | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited States
-
McMaster UniversityNeptuneUnknownObesity | NAFLD | Obesity, Morbid | NASH - Nonalcoholic Steatohepatitis
-
Novartis PharmaceuticalsCompletedObese Patients With Non-alcoholic Steatohepatitis (NASH)Netherlands, Taiwan, Thailand, United States, Israel, Argentina, Russian Federation, Canada
-
Catholic University of the Sacred HeartActive, not recruitingObesity | NAFLD | Obesity, Morbid | NASH - Nonalcoholic SteatohepatitisItaly
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited Kingdom, Spain, United States, France, Germany
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
Institute of Liver and Biliary Sciences, IndiaCompletedNon-alcoholic SteatohepatitisIndia
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Sweden
-
Future MedicineRecruitingFM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisSpain, Hungary, Poland
-
Target PharmaSolutions, Inc.RecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States, Germany, Spain
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Canada
-
Crolll GmbhUniversity of Magdeburg; Estimate, GmbHCompletedNon-alcoholic Steatohepatitis | Increased Iron Storage / Disturbed DistributionGermany
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Maastricht University Medical CenterZuyderland Medical CentreUnknownNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis
-
Oramed, Ltd.IntegriumCompletedDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Israel